유럽 ​​동결건조 주사제 시장 – 2028년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Pharmaceutical Europe Lyophilized Injectable Drugs Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​동결건조 주사제 시장 – 2028년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • Europe
  • 350 Pages
  • 테이블 수: 326
  • 그림 수: 48
지금 구매 지금 구매

>유럽 ​​동결건조 주사제 시장, 포장(바이알, 듀얼 챔버 주사기, 듀얼 챔버 카트리지 및 기타), 약물 종류(항감염제, 항암제, 이뇨제, 양성자 펌프 억제제, 마취제, 항응고제, NSAID, 코르티코스테로이드 및 기타), 형태(분말 및 액체), 적응증(종양학, 자가면역 질환, 호르몬 장애, 호흡기 질환, 위장 장애, 피부 질환, 안과 질환 및 기타), 투여 경로(정맥 주사/주입, 근육 주사 및 기타), 최종 사용자(병원, 진료소, 가정 의료 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타), 국가(독일, 영국, 프랑스, ​​이탈리아, 스페인, 네덜란드, 러시아, 스위스, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드 및 유럽의 나머지 지역) 산업 2028년까지의 추세와 예측

유럽 ​​동결건조 주사제 시장

시장 분석 및 통찰력: 유럽 동결건조 주사제 시장

동결건조 주사제 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 6.3%의 CAGR로 성장하고 있으며 2028년까지 1,612.86백만 달러에 도달할 것으로 예상한다고 분석합니다. 전 세계적으로 만성 건강 문제가 증가함에 따라 동결건조 주사제 시장 수요가 증가할 것으로 예상됩니다.

동결 건조는 동결 건조 의 또 다른 용어입니다 . 진공 상태에서 용액을 동결시키고 증발시켜 용매에서 고체 물질을 분리하는 기술입니다. 동결 건조 제품은 기존 약물보다 유통 기한이 더 긴 것으로 간주되어 선호됩니다. 생물학, 단백질, 항체 미생물, 비경구, 혈장, 효소, 진단 시약, 백신 및 건강 보조 식품의 보호는 일반적으로 동결 건조를 통해 수행됩니다. 일부 불안정한 벌크 성분을 안정적으로 유지하려면 멸균 주사제의 동결 건조가 필요합니다.

동결건조 주사제에 대한 기술적 진보가 증가함에 따라 동결건조 주사제 시장 수요를 촉진하는 원동력이 될 것으로 예상됩니다. 동결건조 약물과 포장 유형에 대한 제품 리콜 건수가 증가함에 따라 동결건조 주사제 시장이 제약을 받을 것으로 예상됩니다. 동결건조 약물에 대한 규제 승인이 증가함에 따라 동결건조 주사제 시장 수요를 촉진하는 기회가 될 것으로 예상됩니다. 비경구용 제품용 동결건조 바이알을 제조하는 것과 관련된 요인이 동결건조 주사제 시장 수요에 도전할 것으로 예상됩니다.

동결건조 주사제 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 동결건조 주사제 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

유럽 ​​동결건조 주사제 시장동결건조 주사제 시장 범위 및 시장 규모

동결건조 주사제 시장은 포장, 약물 종류, 형태, 적응증, 투여 경로, 최종 사용자 및 유통 채널을 기준으로 하는 7가지 주요 세그먼트로 분류됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.

  • 포장 기준으로 동결건조 주사제 시장은 바이알, 듀얼 챔버 주사기, 듀얼 챔버 카트리지 등으로 세분화됩니다. 2021년에는 바이알 부문이 동결건조 주사제 시장을 지배할 것으로 예상되는데, 동결건조 주사제 대부분이 바이알에 포장되어 있기 때문에 시장에 영향력이 있고 성장하고 있기 때문입니다.
  • 약물 분류에 따르면 동결건조 주사제 시장은 항감염제, 항암제, 이뇨제 , 양성자 펌프 억제제, 마취제, 항응고제, NSAID, 코르티코스테로이드 및 기타로 세분화됩니다. 2021년에는 전 세계적으로 항생제와 항바이러스 약물에 대한 수요가 증가함에 따라 항감염제 부문이 동결건조 주사제 시장을 지배할 것으로 예상됩니다.
  • 형태에 따라 동결건조 주사제 시장은 분말 과 액체로 세분화됩니다. 2021년에는 분말 세그먼트가 전 세계적으로 보관 및 운송이 쉽고 안전하기 때문에 동결건조 주사제 시장을 지배할 것으로 예상됩니다.
  • 적응증에 따라 동결건조 주사제 시장은 종양학 , 자가면역 질환, 호르몬 장애, 호흡기 질환, 위장 장애, 피부과 질환, 안과 질환 및 기타로 세분화됩니다. 2021년에는 종양학 분야가 동결건조 주사제 시장의 우위를 차지할 것으로 예상되는데, 이는 종양학을 위한 동결건조 주사제 수의 증가로 인해 가능합니다.
  • 투여 경로를 기준으로 동결건조 주사제 시장은 정맥 주사/주입, 근육 주사 및 기타로 세분화됩니다. 2021년에는 정맥 주사/주입 세그먼트가 이 투여 경로를 통한 약물의 100% 생체이용률로 인해 동결건조 주사제 시장을 지배할 것으로 예상됩니다.
  • On the basis of end user, the lyophilized injectable drugs market is segmented into hospital, clinics, home healthcare and others. In 2021, hospital segment is expected to dominate the lyophilized injectable drugs market due to the financial capabilities of hospitals to purchase luxurious equipment along with the presence of trained professionals to administer them.
  • On the basis of distribution channel, the lyophilized injectable drugs market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is expected to dominate the lyophilized injectable drugs market because most of the service providers buy the lyophilized injectable drugs from manufacturers and it is noticed that revenue from direct sales is higher, so it is influential as well as growing in the market.

유럽 ​​동결건조 주사제 시장Europe Lyophilized Injectable Drugs Market Country Level Analysis

Europe lyophilized injectable drugs market is analysed and market size information is provided by the country, packaging, drug class, form, indication, route of administration, end user and distribution channel as referenced above.

The countries covered in the Europe lyophilized injectable drugs market are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland and rest of Europe.

Vials segment in Germany is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of technological advancements and rising product approval by EMA. France is expected to occupy the second most position in market due to increase in geriatric population with chronic diseases. The vials segment in the U.K. is dominating the European market owing to high demand of safe transit and storage of drugs until their end-use.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

New Product Launches by manufacturers is creating new opportunities for players in the lyophilized injectable drugs market

동결건조 주사제 시장은 또한 동결건조 주사제 시장 판매, 동결건조 주사제 시장 발전의 영향, 동결건조 주사제 시장에 대한 지원과 함께 규제 시나리오의 변화와 함께 모든 국가에 대한 자세한 시장 분석을 제공합니다. 데이터는 2010년부터 2019년까지의 과거 기간에 대해 제공됩니다. 

경쟁 환경 및 동결건조 주사제 시장 점유율 분석

동결건조 주사제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 유럽 동결건조 주사제 시장과 관련된 회사의 초점에만 관련이 있습니다.

유럽 ​​동결건조 주사제 시장 보고서에서 다루는 주요 회사는 Genex Pharma, Aristopharma Ltd., Amneal Pharmaceuticals LLC, Fresenius Kabi Ltd(Fresenius Kabi AG의 자회사), Pfizer Inc., Viatris Inc., Gilead Sciences, Inc., Novartis AG, Otsuka Pharmaceuticals Co., Ltd.(Otsuka Holdings Co., Ltd.의 자회사), Cipla Inc., Cirondrugs, Merck Sharp & Dohme Corp.(Merck & Co., Inc.의 자회사), Sanofi, Celon Laboratories Pvt. Ltd., Baxter 등 국내 기업입니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

또한 전 세계 여러 회사에서 많은 계약과 협정을 체결하면서 동결건조 주사제 시장도 가속화되고 있습니다.

  • 2019년 11월, Pfizer Inc.는 Upjohn이라는 사업부가 Mylan NV와 결합되어 Viatris Inc.라는 새로운 회사를 만들었다고 발표했습니다. 이 회사의 사업부와 Mylan NV의 결합으로 제품 포트폴리오가 확대되어 시장에서 제품 수요가 증가했습니다.

시장 참여자들의 협력, 합작투자 및 기타 전략은 동결건조 주사제 시장에서 회사 시장을 확대하고 있으며, 이를 통해 조직이 동결건조 주사제 시장에 대한 제공 서비스를 개선하는 데에도 도움이 됩니다.

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe lyophilized injectable drugs market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. packaging LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET end user COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: REGULATORY FRAMEWORK
  5. Epidemiology
  6. Market Overview
    1. drivers
      1. rise in chronic health conditions
      2. safe transit and storage of these substances until their end-use
      3. increase in geriatric population with chronic diseases
      4. expansion of pipeline of lyophilized injectable drugs
      5. technological advancements
    2. Restraints
      1. Risk of needlestick injuries
      2. IncreasE IN number of product recalls for lyophilized drugs and packaging type
    3. OPPORTUNITIES
      1. RisE IN regulatory approvals for lyophilized drugs
      2. STRATEGIC INITIATIVES OF KEY MARKET PLAYERS
      3. quality concerns
    4. challenges
      1. challenges associated with manufacturing lyophilized vials for parenteral products
      2. Time-consuming process and high cost
  7. IMPACT OF COVID-19 ON THE EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET
    1. IMPACT ON PRICE
    2. IMPACT IN DEMAND
    3. IMPACT ON SUPPLY
    4. STRATEGIC INITIATIVE
    5. CONCLUSION
  8. Europe lyophilized injectable drugs market, By packaging
    1. overview
    2. vials
    3. Dual-Chamber Syringes
    4. Dual-Chamber Cartridges
    5. Others
  9. Europe lyophilized injectable drugs market, By drug class
    1. overview
    2. Anti-Infective’s
      1. Antibiotics
        1. Azithromycin
        2. Doxycycline
        3. Vancomycin
        4. Polymyxin B
        5. Piperacillin
        6. Tazobactam
        7. Others
      2. Antifungal
        1. Mycamine
        2. Caspofungin Acetate
        3. Isavuconazonium Sulfate
        4. Amphotericin
        5. Others
      3. Antiviral
        1. Acyclovir
        2. Ganciclovir
        3. Remdesivir
        4. Others
      4. Others
    3. Antineoplastic
      1. Methotrexate
      2. Gemcitabine
      3. Cytarabine
      4. Fludarabine
      5. Doxorubicin
      6. Oxaliplatin
      7. Zoledronic Acid
      8. Others
    4. Diuretics
      1. Chlorothiazide
      2. Ethacrynic Acid
      3. Acetazolamide
      4. Others
    5. Proton Pump Inhibitor
      1. Esomeprazole Sodium
      2. Pantoprazole Sodium
      3. Omeprazole
      4. Others
    6. Anesthetic
      1. Vecuronium Bromide
      2. Sodium Thiopental
      3. Lidocaine
      4. Others
    7. Anticoagulant
      1. Coumadin
      2. Urokinase
      3. Antithrombin (Recombinant)
      4. Apixaban
      5. Rivaroxaban
      6. Others
    8. Nsaid’s
      1. Indomethacin
      2. Ibuprofen
      3. Diclofenac
      4. Ketorolac
      5. Others
    9. Corticosteroids
      1. Hydrocortisone
      2. Methylprednisolone
      3. Others
    10. Others
  10. Europe lyophilized injectable drugs market, By form
    1. overview
    2. Powder
    3. Liquid
  11. Europe lyophilized injectable drugs market, By indication
    1. overview
    2. Oncology
    3. Autoimmune Diseases
    4. Hormonal Disorders
    5. Respiratory Diseases
    6. Gastrointestinal Disorders
    7. Dermatological Disorders
    8. Ophthalmic Diseases
    9. Others
  12. Europe lyophilized injectable drugs market, By Route of administration
    1. overview
    2. Intravenous/Infusion
    3. Intramuscular
    4. Others
  13. Europe lyophilized injectable drugs market, By end user
    1. overview
    2. Hospital
    3. Clinics
    4. Home Healthcare
    5. Others
  14. Europe lyophilized injectable drugs market, By distribution channel
    1. overview
    2. Direct Tenders
    3. Retail Sales
    4. Others
    5. Overview
  15. Europe lyophilized injectable drugs market, By Country
    1. europe
      1. Germany
      2. France
      3. U.K.
      4. ITALY
      5. SPAIN
      6. NETHERLANDS
      7. RUSSIA
      8. SWITZERLAND
      9. TURKEY
      10. AUSTRIA
      11. NORWAY
      12. HUNGARY
      13. LITHUANIA
      14. IRELAND
      15. POLAND
      16. REST OF EUROPE
  16. Europe Lyophilized Injectable Drugs Market: COMPANY landscape
    1. company share analysis: Europe
  17. Swot analysis
  18. Company profile
    1. pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    2. Fresenius Kabi Ltd  (a subsidiary of Fresenius Kabi AG)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. Cipla Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    4. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. Merck Sharp & Dohme Corp., A subsidiary of Merck & Co., Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. Baxter
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Amneal Pharmaceuticals LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. Aristopharma Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. celon laboratories pvt.ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Cirondrugs
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. Genex Pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    12. Gilead Sciences, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. Otsuka Pharmaceuticals Co., Ltd. (a subsidiary of Otsuka Holdings Co., Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. sanofi
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    15. viatris Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
  19. questionnaire
  20. related reports

표 목록

TABLE 1 Pipeline lyophilized injectable drugs

TABLE 2 Europe lyophilized injectable drugs market, By packaging, 2019-2028 (USD million)

TABLE 3 Europe lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 4 Europe lyophilized injectable drugs market, By drug class, 2019-2028 (Units)

TABLE 5 Europe Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 6 Europe antibiotics in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 7 Europe antifungal in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 8 Europe antiviral in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 9 europe Antineoplastic in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 10 Europe Diuretics in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 11 europe Proton pump inhibitors in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 12 europe Anesthetics in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 13 europe Anticoagulant in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 14 europe NSAID’s in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 15 europe Corticosteroids in lyophilized injectable drugs market, By drug class, 2019-2028 (USD million)

TABLE 16 europe lyophilized injectable drugs market, By form, 2019-2028 (USD million)

TABLE 17 europe lyophilized injectable drugs market, By indication, 2019-2028 (USD million)

TABLE 18 Europe lyophilized injectable drugs market, By Route of administration, 2019-2028 (USD million)

TABLE 19 europe lyophilized injectable drugs market, By end user, 2019-2028 (USD million)

TABLE 20 Europe lyophilized injectable drugs market, By distribution channel, 2019-2028 (USD million)

TABLE 21 Europe LYOPHILIZED INJECTABLE DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 22 Europe Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 23 Europe Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 24 Europe Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 25 Europe Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 26 Europe Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 27 Europe Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 28 Europe Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 29 Europe Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 30 Europe Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 31 Europe Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 32 Europe Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 33 Europe Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 34 Europe Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 35 Europe Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 36 Europe Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 37 Europe Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 38 Europe Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 39 Europe Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 40 Europe Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 41 Germany Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 42 Germany Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 43 Germany Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 44 Germany Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 45 Germany Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 46 Germany Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 47 Germany Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 48 Germany Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 49 Germany Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 50 Germany Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 51 Germany Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 52 Germany Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 53 Germany Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 54 Germany Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 55 Germany Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 56 Germany Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 57 Germany Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 58 Germany Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 59 Germany Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 France Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 61 France Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 62 France Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 63 France Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 64 France Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 65 France Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 66 France Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 67 France Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 68 France Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 69 France Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 70 France Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 71 France Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 72 France Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 73 France Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 74 France Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 75 France Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 76 France Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 77 France Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 78 France Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 79 U.K. Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 80 U.K. Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 81 U.K. Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 82 U.K. Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 83 U.K. Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 84 U.K. Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 85 U.K. Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 86 U.K. Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 87 U.K. Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 88 U.K. Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 89 U.K. Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 90 U.K. Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 91 U.K. Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 92 U.K. Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 93 U.K. Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 94 U.K. Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 95 U.K. Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 96 U.K. Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 97 U.K. Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 98 ITALY Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 99 ITALY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 100 ITALY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 101 ITALY Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 102 ITALY Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 103 ITALY Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 104 ITALY Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 105 ITALY Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 106 ITALY Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 107 ITALY Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 108 ITALY Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 109 ITALY Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 110 ITALY Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 111 ITALY Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 112 ITALY Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 113 ITALY Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 114 ITALY Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 115 ITALY Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 116 ITALY Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 117 SPAIN Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 118 SPAIN Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 119 SPAIN Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 120 SPAIN Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 121 SPAIN Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 122 SPAIN Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 123 SPAIN Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 124 SPAIN Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 125 SPAIN Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 126 SPAIN Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 127 SPAIN Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 128 SPAIN Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 129 SPAIN Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 130 SPAIN Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 131 SPAIN Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 132 SPAIN Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 133 SPAIN Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 134 SPAIN Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 135 SPAIN Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 136 NETHERLANDS Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 137 NETHERLANDS Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 138 NETHERLANDS Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 139 NETHERLANDS Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 140 NETHERLANDS Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 141 NETHERLANDS Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 142 NETHERLANDS Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 143 NETHERLANDS Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 144 NETHERLANDS Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 145 NETHERLANDS Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 146 NETHERLANDS Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 147 NETHERLANDS Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 148 NETHERLANDS Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 149 NETHERLANDS Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 150 NETHERLANDS Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 151 NETHERLANDS Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 152 NETHERLANDS Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 153 NETHERLANDS Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 154 NETHERLANDS Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 155 RUSSIA Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 156 RUSSIA Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 157 RUSSIA Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 158 RUSSIA Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 159 RUSSIA Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 160 RUSSIA Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 161 RUSSIA Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 162 RUSSIA Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 163 RUSSIA Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 164 RUSSIA Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 165 RUSSIA Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 166 RUSSIA Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 167 RUSSIA Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 168 RUSSIA Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 169 RUSSIA Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 170 RUSSIA Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 171 RUSSIA Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 172 RUSSIA Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 173 RUSSIA Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 174 SWITZERLAND Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 175 SWITZERLAND Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 176 SWITZERLAND Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 177 SWITZERLAND Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 178 SWITZERLAND Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 179 SWITZERLAND Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 180 SWITZERLAND Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 181 SWITZERLAND Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 182 SWITZERLAND Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 183 SWITZERLAND Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 184 SWITZERLAND Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 185 SWITZERLAND Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 186 SWITZERLAND Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 187 SWITZERLAND Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 188 SWITZERLAND Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 189 SWITZERLAND Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 190 SWITZERLAND Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 191 SWITZERLAND Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 192 SWITZERLAND Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 193 TURKEY Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 194 TURKEY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 195 TURKEY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 196 TURKEY Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 197 TURKEY Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 198 TURKEY Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 199 TURKEY Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 200 TURKEY Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 201 TURKEY Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 202 TURKEY Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 203 TURKEY Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 204 TURKEY Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 205 TURKEY Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 206 TURKEY Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 207 TURKEY Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 208 TURKEY Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 209 TURKEY Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 210 TURKEY Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 211 TURKEY Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 212 AUSTRIA Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 213 AUSTRIA Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 214 AUSTRIA Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 215 AUSTRIA Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 216 AUSTRIA Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 217 AUSTRIA Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 218 AUSTRIA Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 219 AUSTRIA Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 220 AUSTRIA Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 221 AUSTRIA Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 222 AUSTRIA Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 223 AUSTRIA Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 224 AUSTRIA Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 225 AUSTRIA Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 226 AUSTRIA Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 227 AUSTRIA Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 228 AUSTRIA Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 229 AUSTRIA Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 230 AUSTRIA Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 231 NORWAY Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 232 NORWAY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 233 NORWAY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 234 NORWAY Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 235 NORWAY Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 236 NORWAY Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 237 NORWAY Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 238 NORWAY Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 239 NORWAY Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 240 NORWAY Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 241 NORWAY Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 242 NORWAY Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 243 NORWAY Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 244 NORWAY Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 245 NORWAY Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 246 NORWAY Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 247 NORWAY Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 248 NORWAY Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 249 NORWAY Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 250 HUNGARY Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 251 HUNGARY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 252 HUNGARY Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 253 HUNGARY Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 254 HUNGARY Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 255 HUNGARY Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 256 HUNGARY Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 257 HUNGARY Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 258 HUNGARY Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 259 HUNGARY Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 260 HUNGARY Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 261 HUNGARY Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 262 HUNGARY Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 263 HUNGARY Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 264 HUNGARY Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 265 HUNGARY Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 266 HUNGARY Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 267 HUNGARY Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 268 HUNGARY Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 269 LITHUANIA Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 270 LITHUANIA Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 271 LITHUANIA Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 272 LITHUANIA Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 273 LITHUANIA Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 274 LITHUANIA Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 275 LITHUANIA Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 276 LITHUANIA Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 277 LITHUANIA Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 278 LITHUANIA Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 279 LITHUANIA Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 280 LITHUANIA Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 281 LITHUANIA Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 282 LITHUANIA Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 283 LITHUANIA Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 284 LITHUANIA Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 285 LITHUANIA Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 286 LITHUANIA Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 287 LITHUANIA Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 288 IRELAND Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 289 IRELAND Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 290 IRELAND Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 291 IRELAND Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 292 IRELAND Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 293 IRELAND Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 294 IRELAND Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 295 IRELAND Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 296 IRELAND Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 297 IRELAND Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 298 IRELAND Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 299 IRELAND Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 300 IRELAND Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 301 IRELAND Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 302 IRELAND Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 303 IRELAND Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 304 IRELAND Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 305 IRELAND Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 306 IRELAND Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 307 POLAND Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

TABLE 308 POLAND Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 309 POLAND Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (Units)

TABLE 310 POLAND Anti-Infectives in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 311 POLAND Antibiotics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 312 POLAND Antifungal in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 313 POLAND Antiviral in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 314 POLAND Antineoplastic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 315 POLAND Diuretics in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 316 POLAND Proton Pump Inhibitor in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 317 POLAND Anesthetic in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 318 POLAND Anticoagulant in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 319 POLAND Nsaid’s in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 320 POLAND Corticosteroids in Lyophilized Injectable Drugs Market, By Drug Class, 2019-2028 (USD Million)

TABLE 321 POLAND Lyophilized Injectable Drugs Market, By Form, 2019-2028 (USD Million)

TABLE 322 POLAND Lyophilized Injectable Drugs Market, By Indication, 2019-2028 (USD Million)

TABLE 323 POLAND Lyophilized Injectable Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 324 POLAND Lyophilized Injectable Drugs Market, By End User, 2019-2028 (USD Million)

TABLE 325 POLAND Lyophilized Injectable Drugs Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 326 REST OF EUROPE Lyophilized Injectable Drugs Market, By Packaging, 2019-2028 (USD Million)

그림 목록

FIGURE 1 Europe LYOPHILIZED INJECTABLE DRUGS MARKET: SEGMENTATION

FIGURE 2 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: DATA TRIANGULATION

FIGURE 3 Europe Lyophilized injectable drugs market: DROC ANALYSIS

FIGURE 4 Europe Lyophilized injectable drugs market: Europe VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Lyophilized injectable drugs market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Lyophilized injectable drugs market: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Lyophilized injectable drugs market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE lyophilized injectable drugs market: MARKET end user COVERAGE GRID

FIGURE 11 Europe Lyophilized injectable drugs market: SEGMENTATION

FIGURE 12 rise in chronic health conditions is expected to DRIVe THE Europe Lyophilized injectable drugs market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 vials SEGMENT is expected to account for the largest share of the Europe LYOPHILIZED INJECTABLE DRUGS MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF Europe LYOPHILIZED INJECTABLE DRUGS Market

FIGURE 15 Europe lyophilized injectable drugs market: By packaging, 2020

FIGURE 16 Europe lyophilized injectable drugs market: By packaging, 2021-2028 (USD Million)

FIGURE 17 Europe lyophilized injectable drugs market: By packaging, CAGR (2021-2028)

FIGURE 18 Europe lyophilized injectable drugs market: By packaging, LIFELINE CURVE

FIGURE 19 Europe lyophilized injectable drugs market: By drug class, 2020

FIGURE 20 Europe lyophilized injectable drugs market: By drug class, 2021-2028 (USD Million)

FIGURE 21 Europe lyophilized injectable drugs market: By drug class, CAGR (2021-2028)

FIGURE 22 Europe lyophilized injectable drugs market: By drug class, LIFELINE CURVE

FIGURE 23 Europe lyophilized injectable drugs market: By form, 2020

FIGURE 24 Europe lyophilized injectable drugs market: By form, 2021-2028 (USD Million)

FIGURE 25 Europe lyophilized injectable drugs market: By form, CAGR (2021-2028)

FIGURE 26 Europe lyophilized injectable drugs market: By form, LIFELINE CURVE

FIGURE 27 Europe lyophilized injectable drugs market: By indication, 2020

FIGURE 28 Europe lyophilized injectable drugs market: By indication, 2021-2028 (USD Million)

FIGURE 29 Europe lyophilized injectable drugs market: By indication, CAGR (2021-2028)

FIGURE 30 Europe lyophilized injectable drugs market: By indication, LIFELINE CURVE

FIGURE 31 Europe lyophilized injectable drugs market: By Route of administration, 2020

FIGURE 32 Europe lyophilized injectable drugs market: By Route of administration, 2021-2028 (USD Million)

FIGURE 33 Europe lyophilized injectable drugs market: By Route of administration, CAGR (2021-2028)

FIGURE 34 Europe lyophilized injectable drugs market: By Route of administration, LIFELINE CURVE

FIGURE 35 Europe lyophilized injectable drugs market: By end user, 2020

FIGURE 36 Europe lyophilized injectable drugs market: By end user, 2021-2028 (USD Million)

FIGURE 37 Europe lyophilized injectable drugs market: By end user, CAGR (2021-2028)

FIGURE 38 Europe lyophilized injectable drugs market: By end user, LIFELINE CURVE

FIGURE 39 Europe lyophilized injectable drugs market: By distribution channel, 2020

FIGURE 40 Europe lyophilized injectable drugs market: By distribution channel, 2021-2028 (USD Million)

FIGURE 41 Europe lyophilized injectable drugs market: By distribution channel, CAGR (2021-2028)

FIGURE 42 Europe lyophilized injectable drugs market: By distribution channel, LIFELINE CURVE

FIGURE 43 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: SNAPSHOT (2020)

FIGURE 44 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: BY COUNTRY (2020)

FIGURE 45 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 46 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET: BY TYPE (2021-2028)

FIGURE 48 Europe Lyophilized Injectable Drugs Market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

관련 페이지 탐색

Banner